Giannitrapani, K. F. http://orcid.org/0000-0003-0987-6204
Silveira, M. J.
Azarfar, A.
Glassman, P. A.
Singer, S. J.
Asch, S. M.
Midboe, A. M.
Zenoni, M. A.
Gamboa, R. C.
Becker, W. C.
Lorenz, K. A.
Funding for this research was provided by:
U.S. Department of Veterans Affairs (SDR:15-461)
Article History
Received: 24 February 2020
Accepted: 18 March 2021
First Online: 4 May 2021
Declarations
:
: Qualitative data was collected as part of the Opioid CHOICE project, approved by the VA Palo Alto/Stanford University Institutional Review Board (IRB) [protocol number 35889].
: All of the authors report grants from Department of Veterans Affairs during the conduct of the study. Dr. Glassman reports nonfinancial support from U.S. Pharmacopeia as well as nonfinancial support and others from the Food and Drug Administration, outside the submitted work. All other authors declare that they do not have a conflict of interest. This work represents solely the perspectives of the authors and does not reflect the opinions of the authors’ affiliated universities, the Department of Veterans Affairs, or the US Government.
Free to read: This content has been made available to all.